We are delighted to expand our long-standing collaboration with Fluxion Biosciences! For more than twelve years, we have been successfully offering Fluxion's innovative Bioflux systems in Germany, Austria and France. This partnership enables us to provide groundbreaking solutions for emulating in vivo conditions by introducing physiological shear flow into your research and drug discovery experiments.
In addition to our current territories, we will now offer the BioFlux product range in Switzerland, the BeNeLux countries, Denmark, Sweden, Norway and Finland. This is an important step for us, enabling us to support researchers and scientists in these regions too.
The BioFlux series is renowned for the functional analysis of cellular interactions under shear flow conditions and is used, for example, in haematology (platelet-/thrombosis-assays), oncology (CART-T cell therapy) or in the biofilms formation research.
Hundreds of laboratories around the world rely on Fluxion Biosciences' solutions to explore novel biology, accelerate new drug development and estanblish therapies based on patient-specific biomarkers.
We would like to thank our partner Fluxion Biosciences for their confidence in us and look forward to further exciting collaborations. Please do not hesitate to contact us if you have any questions or require advice.
Learn more about the Fluxion BioFlux Live Cell Imaging Systems: (Link)
